Series Description: 

Multidisciplinary and interprofessional experts (i.e., specialties including surgery, radiology, and medical or radiation oncology) thoroughly review complex oncology cases and discuss treatment recommendations. The series is designed with the goal of promoting multidisciplinary approaches to treatment planning and leveraging the expertise of the interprofessional cancer care team in sharing of knowledge, emerging evidence, and collaborative responsibility of care. Case discussions include staging, treatment options, and recommendations for clinical trial participation. Participants will evaluate current data and updates on evidence-based clinical best practice information, such as current NCCN guidelines, in making treatment recommendations for these cases.

Target Audience: 

Nurse Practitioner (NP)

Nurse, Registered (RN)

Physicians (MD or DO)

Social Workers

Other Healthcare Professionals

Learning Objectives- After Attending this Activity, Learners Should be Able to:

1. Discuss evidence-based use of diagnostic studies, systemic, and integrative medicine approaches in the treatment of tumors.
2. Formulate multidisciplinary recommendations for cancer treatments, and applications to individual patient cases based on data, patient preferences confirmed via shared decision-making, and current research.
3. Evaluate multifaceted cases, where findings and treatments are not apparent to develop individualized care plans for hard to solve cases for support from the interprofessional care team.
4. Demonstrate cultural humility in the ability to deliver culturally appropriate care, free of implicit biases, for families of diverse cultural backgrounds and belief systems. This includes learning from the patients and families directly about how they perceive health and illness as well as respond to various diseases, symptoms, and treatments.

Providing Culturally Appropriate Care which is Free of Implicit Biases (AB 1195 & 241):

Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases via the references provided below:

1. American Association for Cancer Research Cancer Disparities Progress Report (2022). https://cancerprogressreport.aacr.org/disparities/?utm_source=digital&utm_medium=sem&campaign=disparities-report&gclid=EAIaIQobChMIv4C_wIe8_QIVEx19Ch0l1AmjEAAYASAAEgIDDfD_BwE
2. Mayden, K. (2021). Improving health equity: The role of the oncology advanced practitioner in managing implicit bias. Journal of the Advanced Practitioner in Oncology; 12(8): 868-874. doi: 10.6004/jadpro.2021.12.8.7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631340/
3. Sarfati, D. (2019). Why social inequalities matter in the cancer continuum. Reducing social inequalities in Cancer: Evidence and Priorities for Research. https://www.ncbi.nlm.nih.gov/books/NBK566166/

Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest:

Xin Li, faculty for this presentation, receives consultant fees from Aptitude Health. This relevant ineligible relationships was mitigated via a Speaker Agreement form attesting to accreditation requirements.

No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.   

– Provider Designee/Verification:  Kerri Maya, PhD(c), MSL, RN, NPD-BC